Data of Inflammatory Parameters after Anti-coagulant among Moderate, Severe, and Critically Ill COVID-19 Patients

This dataset consists of 331 enrolled patients for a study entitled "The Improvement of Inflammatory Markers and Disease Progression among Moderate, Severe, and Critically Ill COVID-19 Patients: A Study from Two-Second Referral Hospitals in Surabaya, Indonesia". We recorded baseline characteristics and laboratory parameters in three timeframes of evaluation.